Renal dipeptidase purified from swine kidney hydrolyzed N-formimidoyl thienamycin, carpetimycins A and B, and Sch29482, but not azthreonam, penicillin G, or cephaloridine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC183816 | PMC |
| http://dx.doi.org/10.1128/AAC.22.4.693 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Insight into dipeptidase 1: structure, function, and mechanism in gastrointestinal cancer diseases.
Transl Cancer Res
December 2024
Department of Oncology, Jiangdu People's Hospital Affiliated to Yangzhou University, Yangzhou, China.
Dipeptidase 1 (DPEP1), initially identified as a renal membrane enzyme in mature human kidneys, plays a pivotal role in various cellular processes. It facilitates the exchange of materials and signal transduction across cell membranes, contributing significantly to dipeptide hydrolysis, glucose and lipid metabolism, immune inflammation, and ferroptosis, among other cellular functions. Extensive research has delineated the complex role of DPEP1 in oncogenesis and tumor progression, with its influence being context dependent.
View Article and Find Full Text PDF[Evaluation of the toxicity of perfluorooctanoic acid toward human colorectal cancer cells using multi-dimensional approaches].
Se Pu
January 2025
School of Marine Sciences, Sun Yat-sen University, Zhuhai 519082, China.
Article Synopsis
- Human exposure to perfluorooctanoic acid (PFOA) can lead to ulcerative colitis, but the mechanisms of its toxicity in intestinal cells remain unclear.
- Researchers studied the effects of PFOA on human colorectal cancer cells (HCT116) by examining cell viability, mitochondrial activity, and gene expression related to metabolism.
- They found that 300 μmol/L of PFOA significantly reduced the viability of HCT116 cells and altered metabolic gene expression, while lower concentrations (50 μmol/L) increased mitochondrial respiratory activity.
- The study suggests that mitochondrial activity could indicate PFOA's effects, and specific genes could play a role in the development of ulcerative colitis linked to PFOA exposure
Mendelian Randomization Analysis of Non-small Cell Lung Cancer and Five Exposure Factors Based on Pathway Enrichment Analysis.
J Cancer
October 2024
Department of Cardiovascular Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China, 330006.
Article Synopsis
- The initiative focuses on using Mendelian randomization to identify causal risk factors for non-small cell lung cancer (NSCLC), which can inform prevention strategies.
- The analysis utilized data from the GEO database to find differentially expressed genes and employed pathway enrichment analysis to screen for exposure factors related to NSCLC.
- Five exposure factors—coronary atherosclerosis and specific adhesion molecules—were found to negatively correlate with NSCLC risk, suggesting that higher levels of these factors might lower the chances of developing the disease, with reliable results indicating no heterogeneity or pleiotropy.
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer.
J Gastroenterol
September 2024
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, 467-8601, Japan.
Artificial intelligence-enhanced electrocardiography derived body mass index as a predictor of future cardiometabolic disease.
NPJ Digit Med
June 2024
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
The electrocardiogram (ECG) can capture obesity-related cardiac changes. Artificial intelligence-enhanced ECG (AI-ECG) can identify subclinical disease. We trained an AI-ECG model to predict body mass index (BMI) from the ECG alone.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!